ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 (ORIAW)

CUSIP: G6780C117

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / *W EXP 04/15/202
Total 13F shares
2,477,949
Share change
-61,655
Total reported value
$495,028
Price per share
$0.08
Number of holders
23
Value change
-$7,229
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP G6780C117?
CUSIP G6780C117 identifies ORIAW - ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 (ORIAW) as of Q1 2023

As of 31 Mar 2023, ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 (ORIAW) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,477,949 shares. The largest 10 holders included Periscope Capital Inc., GRITSTONE ASSET MANAGEMENT LLC, 683 Capital Management, LLC, KIM, LLC, MMCAP International Inc. SPC, Linden Advisors LP, CANTOR FITZGERALD, L. P., Shaolin Capital Management LLC, Arena Capital Advisors, LLC- CA, and P SCHOENFELD ASSET MANAGEMENT LP. This page lists 23 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.